AMRX

Vorhandelsmarkt: 19.50 0.17 +0.88%

Amneal Pharmaceuticals Inc (AMRX)

Überblick Nachrichten Preisverlauf Optionskette Forum Prognose

Schlusskurs vom Vortag:

24-Stunden-Volumen:

Relative Volume:

Marktkapitalisierung:

Nettoeinkommen (Verlust:

Netto-Cashflow:

1W Leistung:

1M Leistung:

6M Leistung:

1J Leistung:

1-Tages-Spanne:

1-Wochen-Bereich:

52-Wochen-Spanne:

Amneal Pharmaceuticals Inc Stock (AMRX) Company Profile

Amneal Pharmaceuticals Inc

Healthcare (1065)

908-947-3120

400 Crossing Boulevard, 3rd Floor, Bridgewater

@amnealpharma

Nächster Verdiensttermin

Neueste SEC-Einreichungen

AMRX's Discussions on Twitter

Compare AMRX vs TAK, TEVA, HLN, ZTS, UTHR

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
AMRX Amneal Pharmaceuticals Inc	19.33	6.73B	3.05B	181.32M	186.11M	0.373
TAK Takeda Pharmaceutical Co Adr	18.81	60.07B	29.91B	1.30B	3.49B	0.4056
TEVA Teva Pharmaceutical Industries Ltd Adr	39.01	45.50B	17.53B	1.58B	444.18M	1.3457
HLN Haleon Plc Adr	9.11	40.06B	14.54B	2.22B	2.58B	0.4871
ZTS Zoetis Inc	71.61	29.59B	9.51B	2.64B	2.14B	6.0361
UTHR United Therapeutics Corp	489.42	20.99B	3.17B	1.29B	1.01B	27.09

Amneal Pharmaceuticals Inc Stock (AMRX) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2026-04-17	Eingeleitet	UBS	Buy
2025-12-09	Eingeleitet	Barclays	Overweight
2025-06-06	Eingeleitet	Goldman	Buy
2025-02-24	Hochstufung	JP Morgan	Neutral → Overweight
2024-09-06	Hochstufung	JP Morgan	Underweight → Neutral
2021-04-07	Fortgesetzt	RBC Capital Mkts	Sector Perform
2021-03-08	Hochstufung	Goldman	Sell → Buy
2020-12-14	Hochstufung	Barclays	Equal Weight → Overweight
2020-12-14	Hochstufung	Guggenheim	Neutral → Buy
2020-07-27	Eingeleitet	Goldman	Sell
2020-05-12	Hochstufung	Guggenheim	Sell → Neutral
2019-12-12	Herabstufung	Raymond James	Outperform → Mkt Perform
2019-11-12	Herabstufung	JP Morgan	Neutral → Underweight
2019-11-07	Herabstufung	SVB Leerink	Outperform → Mkt Perform
2019-07-22	Hochstufung	SVB Leerink	Mkt Perform → Outperform
2019-07-11	Herabstufung	RBC Capital Mkts	Outperform → Sector Perform
2019-07-08	Hochstufung	Piper Jaffray	Neutral → Overweight
2019-06-11	Eingeleitet	Barclays	Equal Weight
2019-05-21	Hochstufung	Raymond James	Mkt Perform → Strong Buy
2019-03-20	Eingeleitet	SunTrust	Buy
2019-03-08	Herabstufung	SVB Leerink	Outperform → Mkt Perform
2018-12-14	Herabstufung	Morgan Stanley	Overweight → Equal-Weight
2018-10-16	Herabstufung	SunTrust	Buy → Hold
2018-08-13	Hochstufung	RBC Capital Mkts	Sector Perform → Outperform
2018-07-23	Eingeleitet	Morgan Stanley	Overweight
2018-06-22	Eingeleitet	B. Riley FBR, Inc.	Buy

Alle ansehen

Amneal Pharmaceuticals Inc Aktie (AMRX) Neueste Nachrichten

Finanzdaten der Amneal Pharmaceuticals Inc-Aktie (AMRX)

Amneal Pharmaceuticals Inc (AMRX)

Amneal Pharmaceuticals Inc Stock (AMRX) Company Profile

Compare AMRX vs TAK, TEVA, HLN, ZTS, UTHR

Amneal Pharmaceuticals Inc Stock (AMRX) Upgrades & Downgrades

Amneal Pharmaceuticals Inc Aktie (AMRX) Neueste Nachrichten

Amneal Pharmaceuticals' Biosimilars, Specialty Growth Reshape Earnings Profile, Oppenheimer Says - marketscreener.com

Oppenheimer initiates Amneal Pharmaceuticals stock with outperform rating - Investing.com

Form 4 Amneal Pharmaceuticals Inc Class A For: 23 September - Investing.com India

Form 4 Amneal Pharmaceuticals Inc Class A For: 23 September By Investing.com - Investing.com Australia

Amneal Pharmaceuticals, Inc. (AMRX) stock price, news, quote and history - uk.finance.yahoo.com

Form 4 Amneal Pharmaceuticals Inc Class A For: 22 September By Investing.com - Investing.com Nigeria

Amneal: Even My Bull Case Barely Justifies $20/Share (NASDAQ:AMRX) - Seeking Alpha

Amneal Pharmaceuticals, Inc. (AMRX) Stock Price, News, Quote & History - Yahoo! Finance Canada

Amneal Pharmaceuticals Inc (AMRX) Shares Surge 7.8% -- What GF S - GuruFocus

Amneal Pharmaceuticals Director Kevin J. Buchi Transfers 20,445 Shares to Trust - kalkinemedia.com

Why Is Amneal (AMRX) Stock Rocketing Higher Today - Yahoo Finance

Amneal (NASDAQ: AMRX) director gifts 20,445 shares to trust he oversees - stocktitan.net

Amneal Pharmaceuticals Jumps 6.4% After Barclays Maintains Overweight - AlphaStreet

Amneal Pharmaceuticals stock hits 52-week high at 19.32 USD - Investing.com

Amneal Launches Its Generic Lanreotide Immediately While the Brand Still Posts Nearly a Billion in US Sales - Medical Daily

Amneal Pharmaceuticals stock gains after FDA approval for lanreotide injection - AD HOC NEWS

Amneal receives FDA approval for generic lanreotide injection By Investing.com - Investing.com Nigeria

AMRX Stock Advances As Generic To Ipsen’s Hormone Shot Gets FDA Nod - Yahoo Finance

Stocks to Watch : Paramount Skydance, Warner Bros. Discovery, Accenture, Amneal Pharmaceuticals - marketscreener.com

Amneal receives FDA approval for generic lanreotide injection - Investing.com

An injection for three conditions launches immediately after FDA approval - stocktitan.net

Amneal (AMRX) Surges 8.6%: Is This an Indication of Further Gains? - Eastern Progress

Amneal Pharmaceuticals Inc. (AMRX) Stock Price | Live Quotes & Charts | NASDAQ - timothysykes.com

Amneal Pharmaceuticals Inc (AMRX) Stock Down 3.3% but Still Over - GuruFocus

Insider Unloading: KEVIN BUCHI Sells Options, Realizes $54K - Benzinga

Kentucky Gov. Andy Beshear visits Amneal's Glasgow facility - goSkagit

Amneal Pharmaceuticals, Inc.Class A Common Stock (NQ: AMRX - The Chronicle-Journal

Leerink Partners Initiates Coverage on Amneal Pharmaceuticals With Outperform, $23 Price Target - marketscreener.com

Does Amneal’s New US$523 Million Shelf Registration Reframe Its Capital Allocation Story for AMRX? - simplywall.st

Does Amneal’s Post‑Earnings Shelf Registration Reshape the Bull Case for Amneal Pharmaceuticals (AMRX)? - Yahoo Finance

Amneal Pharmaceuticals (AMRX) Bets Big On Biosimilars While Wall Street Retreats - Yahoo Finance

Amneal Pharmaceuticals (AMRX) Stock Sees Modest Fair Value Lift On Launch Optimism - Yahoo Finance

US FDA is working with manufacturers to boost estrogen patch supply amid access concerns - Reuters

Amneal Pharmaceuticals files prospectus for sale of up to 28.9 million shares - scanx.trade

Amneal Pharmaceuticals (AMRX) Following Its Biosimilars Push And The Fair Value Debate - simplywall.st

Generic Pharmaceuticals Stocks Q2 Results: Benchmarking Amneal (NASDAQ:AMRX) - Yahoo Finance

Amneal Pharmaceuticals Says US FDA Approves Romidepsin Injection Solution - Moomoo

J.P. Morgan Maintains Amneal Pharmaceuticals(AMRX.US) With Buy Rating, Raises Target Price to $22 - Moomoo

Amneal builds end-to-end biosimilars capacity in the U.S. - Chain Drug Review

Amneal Pharmaceuticals (AMRX) Stock Looks Fairly Valued But Earnings Still Look Rich - sahmcapital.com

Amneal (AMRX) Results Review: Profit Per Share Clears Its Benchmark in Latest Trading; Closing Reaction: The Share Price Adds 1.87% in the Current UpdateProfit Warning Alert - Vinanet

Amneal (AMRX) Earnings Report: EPS Beats Its Estimate in Latest Trading; The Market Price Declines 1.25% in the Latest SessionDiluted EPS Report - vinanet.vn

STOCK ALERT: Kaskela Law Announces Shareholder Investigation of Amneal Pharmaceuticals, Inc. (AMRX) and Encourages Current AMRX Stockholders to Contact the Firm - Business Wire

Zacks.com featured highlights include CareDx, Healthcare Services, Forum Energy Tech, Amneal Pharma and Caterpillar - Yahoo Finance

Amneal (AMRX) Stock Looks Fairly Valued Following Raised 2026 Guidance - Sahm

Is Amneal Pharmaceuticals (AMRX) Fairly Valued After A 3.5x Return? - Yahoo Finance

AMRX Q2 2026 Earnings: Strong EPS Beat Drives 5.1% RallyEarnings Revision Upgrade - vinanet.vn

Amneal Pharmaceuticals Director John Kiely Sells 50,000 Shares and Donates 10,000 Shares on August 13, 2026 - Kalkine Media

A Look at Amneal Pharmaceuticals Inc (AMRX) After 5.1% Gain -- G - GuruFocus

Insider Selling: Amneal Pharmaceuticals (NASDAQ:AMRX) Director Sells $882,000.00 in Stock - MarketBeat

Amneal Pharmaceuticals (AMRX) director sells 50,000 shares, gifts 10,000 to charity - Stock Titan

Finanzdaten der Amneal Pharmaceuticals Inc-Aktie (AMRX)

Umsatz

Nettogewinn

Free Cashflow

ENV

Ähnlich wie AMRX